Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Encision Inc. ECIA OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
30/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Encision Inc. (ECIA) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $0.18. It has a SharesGrow Score of 28/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $7M, -5%/yr average growth. Net income is $220,198 (loss), growing at -66.6%/yr. Net profit margin is -3.4% (negative). Gross margin is 53.6% (+4.2 pp trend).

Balance sheet: total debt is $1M against $2M equity (Debt-to-Equity (D/E) ratio 0.8, moderate). Current ratio is 1.66 (strong liquidity). Debt-to-assets is 35.8%. Total assets: $4M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 25/100 (Fail), Health 50/100 (Partial), Moat 50/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).

ECIA SharesGrow Score Overview

30/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 50/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ECIA

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
ECIA: -5%/yr revenue is, -66.6%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
ECIA: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
50/100
Balance sheet ECIA: Debt-to-Equity (D/E) ratio 0.8 (moderate), Current ratio is 1.66 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
50/100
ECIA: Gross margin is 53.6% (+4.2 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 50/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
ECIA: Net profit margin is -3.4%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.09-0.48
Volume158.69K
Avg Volume (30D)4.19K
Market Cap$2.24M
Beta (1Y)0.91
Share Statistics
EPS (TTM)-0.02
Shares Outstanding$11.88M
IPO Date2004-01-02
Employees22
CEORobert H. Fries
Financial Highlights & Ratios
Revenue (TTM)$6.56M
Gross Profit$3.51M
EBITDA$-95.08K
Net Income$-220.2K
Operating Income$-171.98K
Total Cash$257.43K
Total Debt$1.31M
Net Debt$1.06M
Total Assets$3.67M
Price / Earnings (P/E)-9.7
Price / Sales (P/S)0.34
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS29254Q1040

Price Chart

Track all markets on TradingView
ECIA
Encision Inc. ↗  ·  Other OTC
Healthcare • Medical - Instruments & Supplies
0.09 52WK RANGE 0.48

People Also View

SCIA
SCIA
SCI Engineered Materials, Inc.
$5.10
+1.19%
 ETCC
ETCC
Environmental Tectonics Corporation
$0.72
+0.03%
 SCND
SCND
Scientific Industries, Inc.
$0.54
-28.00%
 PCYN
PCYN
Procyon Corporation
$0.28
+0.00%
 EKCS
EKCS
Electronic Control Security Inc.
$0.00
+0.00%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message